𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response to “MtDNA depletions and deletions may also important in pathogenesis of lung cancer”

✍ Scribed by Yang Ai, Sylvia Si; Hsu, Kenneth; Herbert, Cristan; Cheng, Zujian; Hunt, John; Lewis, Craig R.; Thomas, Paul S.

Book ID
122642327
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
165 KB
Volume
107
Category
Article
ISSN
0954-6111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to dual blockade of epidermal g
Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor
✍ Shirish M. Gadgeel; Shadan Ali; Philip A. Philip; Fakhara Ahmed; Antoinette Wozn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB 👁 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) have demonstrated clinical benefit in patients with nonsmall cell lung cancer (NSCLC), particularly those with tumors that have EGFR‐TK domain mutations. Moreover, the EGFR and cyclooxygenase (COX)‐2

Marimastat may not improve survival over
Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.
✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB